We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Host Hotels & Resorts
HST
$17.2B
| $650K | 0.01% |
+41,125
| New | +$770K |
|
|
SPLS
527
CALL
DELISTED
Staples Inc
SPLS
| $645K | 0.01% |
55,000
+54,750
| +21,900% | +$771K |
|
528
Marriott International
MAR
$98.3B
| $643K | 0.01% |
9,432
-8,917
| -49% | -$645K |
|
|
LTC
529
LTC Properties
LTC
$2.06B
| $640K | 0.01% |
+15,000
| New | +$636K |
|
|
SPLS
530
DELISTED
Staples Inc
SPLS
| $634K | 0.01% |
54,088
+12,144
| +29% | +$171K |
|
|
CBAY
531
DELISTED
Cymabay Therapeutics
CBAY
| $623K | 0.01% |
321,158
-229,790
| -42% | -$626K |
|
532
CALL
Tesla
TSLA
$1.23T
| $621K | 0.01% |
37,500
+37,350
| +24,900% | +$635K |
|
533
Illumina
ILMN
$31B
| $615K | 0.01% |
3,598
+2,364
| +192% | +$478K |
|
534
Williams Companies
WMB
$87.5B
| $610K | 0.01% |
16,514
-633
| -4% | -$31.5K |
|
535
Radian Group
RDN
$5.18B
| $608K | 0.01% |
+38,232
| New | +$682K |
|
536
Morgan Stanley
MS
$331B
| $607K | 0.01% |
19,265
+2,265
| +13% | +$82.4K |
|
|
AKS
537
DELISTED
AK Steel Holding Corp
AKS
| $602K | 0.01% |
250,000
-250,800
| -50% | -$730K |
|
|
MHFI
538
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $602K | 0.01% |
6,963
-117,162
| -94% | -$11.5M |
|
539
TransDigm Group
TDG
$70.2B
| $600K | 0.01% |
2,825
-37,684
| -93% | -$8.62M |
|
540
Oracle
ORCL
$374B
| $584K | 0.01% |
16,159
-30,648
| -65% | -$1.18M |
|
541
Enovis
ENOV
$1.68B
| $576K | 0.01% |
11,193
+7,375
| +193% | +$489K |
|
542
Baxter International
BAX
$13.5B
| $575K | 0.01% |
17,504
-34,123
| -66% | -$1.29M |
|
543
Energizer
ENR
$1.44B
| $573K | 0.01% |
+14,803
| New | +$593K |
|
|
KDNY
544
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $570K | 0.01% |
5,881
-972
| -14% | -$116K |
|
545
Weyerhaeuser
WY
$18B
| $568K | 0.01% |
+20,778
| New | +$613K |
|
|
GCI
546
DELISTED
Gannett Co., Inc
GCI
| $556K | 0.01% |
+37,777
| New | +$494K |
|
547
Keysight
KEYS
$54.5B
| $554K | 0.01% |
17,958
+1,106
| +7% | +$34.5K |
|
548
Cencora
COR
$60.6B
| $544K | 0.01% |
5,730
-2,342
| -29% | -$246K |
|
549
Penumbra
PEN
$12.7B
| $543K | 0.01% |
+13,536
| New | +$548K |
|
550
Goldman Sachs
GS
$300B
| $537K | 0.01% |
3,093
-3,321
| -52% | -$651K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.